Advanced Therapies 2024 unites leaders from across the world, to give insight and to promote collaboration to accelerate the development & commercialisation of next generation medicines, bring them to market and help change patient lives. For the past 18 years, the Advanced Therapies Congress has evolved and grown into the leading cell and gene conference and exhibition globally, with hundreds of speakers, thousands of attendees and hundreds of networking opportunities.
The Advanced Therapies Congress features speakers from across the entire value chain of cell and gene therapy development; forward-thinking pharma, biotech and startup companies, researchers, clinicians, academics, HTAs, payers, regulators.
New for 2024: Gene Editing Track
Latest advances in gene editing technologies such as CRISPR and Zinc Finger Nucleases as well as the ethical implications and how they are revolutionising gene therapy and gene modified cell therapies.
Immunotherapy Track
Latest clinical updates in the immunotherapy and immune-oncology space and exploring how biologic and bispecific therapies are working together with cell and gene therapies to help combat cancer.
With 8 tracks of content, the agenda covers everything from manufacturing, supply chain & logistics, pricing & market access, to developments in key therapeutic areas; cell therapy, gene therapy, gene modified cell therapy, gene editing, stem cells and regenerative medicine, and much more.
Location
ExCeL London
One Western Gateway
Royal Victoria Dock
London
E16 1XL
Learn more and register here: https://www.terrapinn.com/congress/advanced-therapies/index.stm
